10-92239898-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_014912.5(CPEB3):āc.453C>Gā(p.Phe151Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000992 in 1,612,336 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 33)
Exomes š: 0.000010 ( 0 hom. )
Consequence
CPEB3
NM_014912.5 missense
NM_014912.5 missense
Scores
3
7
9
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
CPEB3 (HGNC:21746): (cytoplasmic polyadenylation element binding protein 3) Enables mRNA 3'-UTR binding activity and translation factor activity, RNA binding. Involved in cellular response to amino acid stimulus; negative regulation of transcription by RNA polymerase II; and positive regulation of mRNA catabolic process. Located in several cellular components, including cytosol; midbody; and nucleoplasm. Part of CCR4-NOT complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 15 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPEB3 | NM_014912.5 | c.453C>G | p.Phe151Leu | missense_variant | 2/10 | ENST00000265997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPEB3 | ENST00000265997.5 | c.453C>G | p.Phe151Leu | missense_variant | 2/10 | 1 | NM_014912.5 | ||
CPEB3 | ENST00000412050.8 | c.453C>G | p.Phe151Leu | missense_variant | 2/10 | 1 | P1 | ||
CPEB3 | ENST00000614585.4 | c.453C>G | p.Phe151Leu | missense_variant | 2/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151822Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151822
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 246960Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134120
GnomAD3 exomes
AF:
AC:
5
AN:
246960
Hom.:
AF XY:
AC XY:
2
AN XY:
134120
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460514Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726550
GnomAD4 exome
AF:
AC:
15
AN:
1460514
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
726550
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151822Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74174
GnomAD4 genome
AF:
AC:
1
AN:
151822
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74174
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2023 | The c.453C>G (p.F151L) alteration is located in exon 2 (coding exon 1) of the CPEB3 gene. This alteration results from a C to G substitution at nucleotide position 453, causing the phenylalanine (F) at amino acid position 151 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Pathogenic
D;D;.
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;N
REVEL
Uncertain
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
D;P;P
Vest4
MutPred
Loss of glycosylation at S152 (P = 0.1157);Loss of glycosylation at S152 (P = 0.1157);Loss of glycosylation at S152 (P = 0.1157);
MVP
MPC
0.90
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at